Month: September 2019

TRADE ALERT: The market may be rotating to value stocks but our Algo remains bullish on MSFT. What is more, we are able to Buy at below $120 per share. Read Full Strategy: http://bit.ly/2ZKMxTx

TRADE ALERT: Citigroup’s Edward Morse sees Gold trading at $2,000 over the next two years. We are able to Buy the SPDR Gold Trust (GLD) – the world’s largest Gold ETF backed by physical gold bullion – 10% below market. Read Full Strategy: http://bit.ly/2ZKMxTx

On net, nearly $6 billion flowed into U.S.-listed ETFs during the week ending Thursday, Sep. 5, according to FactSet. That puts year-to-date inflows at $150.7 billion, less than the $176.1 billion at this same time last year. U.S. Fixed Income ETFs picked up $3.7 billion. Bank of America Merrill Lynch is bullish on risk assets for 2019. Read Full Strategy: http://bit.ly/2N84lCv

TRADE ALERT: Make 42% In 12 Months: Walt Disney Has The Deepest, Richest Library Of Characters And Shows On The Planet. Disney Paid $71 Billion For 20th Century Fox And $5.8 billion to take over Hulu. Using Interbank Equity Options, We Are Able To Make 34% On Disney. Read Full Strategy: bit.ly/2MP6ZMq

In the week ended Tues, 3 Sep, Traders increased Euro short positions by 10K contracts, bringing the total to 49K from 39K in the previous week. BofAML remains bearish on Euro. Read Full Strategy: http://bit.ly/2ZUu2s8

TRADE ALERT: GBP/USD has just broken above $1.23 and our Algo now sees further upside. Major support is now at $1.2153. Read Full Strategy: http://bit.ly/2LivYq0

Make 26% In 12 Months From A Cancer Play: This Co’s experimental cancer drug has shown promise in treating a cancer mutation known as KRAS G12C. Medicines targeting KRAS have the potential to be a $2 billion or more class of drugs. Read Full Strategy: http://bit.ly/2Liu8W4

BofAML’s investor position indicator, which tracks 18 measurements on asset flow, sentiment, and price, is falling below 2.0 for the first time since January—a level that signals that investor positions are extremely bearish and triggers a contrarian buy signal for risk assets. Read Full Strategy: http://bit.ly/2ZEIIeN

Using mRNA as a medicine is a fundamentally different approach than treating disease with other drug classes. What is mRNA? mRNA is the set of instructions by which cells make all proteins and send them to various parts of the body. Why mRNA? mRNA medicines take advantage of normal biological processes to express proteins and create a desired therapeutic effect. This enables the potential treatment of a broad spectrum of diseases, many of which cannot be addressed with current technologies. Read Full Strategy: http://bit.ly/2ZJpc0y

In the week ended 29 Aug, Investors bought $1.24 billion of SPDR Gold Trust (GLD). The biggest ETF backed by physical Gold, we are able to Accumulate 10% below market and deliver returns of 15%. ANZ and Deutsche bank see the major gold buying spree by central banks increasing in the coming years. Read Full Strategy: http://bit.ly/2LaGD69